Thursday, October 15, 2026

Back to today

Modine Deep Dive

Modine, soon Modexus Solutions, has a $4 billion hyperscaler cooling contract but must ramp factory output and restore margins as data center sales target 60% to 80% growth.

From X

@InvestSpecial

Dalius - Special Sits on X

Love me some microcap crap. $GLND, an early-stage oil exploration company in Greenland, has just more than doubled in value. Well, of course, the Greenland-Denmark-US security agreement was announced. It all makes sense now: there is oil in Greenland, so obviously the agreement means the oil will be extracted. Perfect connection. To be serious, though, this is one of the most promotional stories I’ve seen recently. Why? GLND plans to drill what the CEO claims could be $1T worth of oil reserves in Greenland. The problem is that not a single well has ever been drilled on this land. The company does not even have the green light to drill yet. And btw, GLND doesn’t even own the licence. $80M.L owns it and is currently being acquired by GLND. The spread is extremely wide, but I wouldn’t touch it. The whole thing smells fishy. 80M.L and its management also have a terrible track record of dilution built around promises of enormous exploration potential across other Greenland projects. Unsurprisingly, very little came of those stories. The worst part here is the media coverage. It largely misses the promotional nature of the story and instead keeps feeding the Trump/Greenland narrative that management appears happy to lean into. That is also why you now get a huge move in GLND on a security agreement that, as far as the underlying oil project is concerned, changes essentially nothing. Microcap world is a fun place to be.

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…

BLND · long

Blend Labs INC

Blend Labs (BLND) is presented as a long investment idea, with prior VIC writeups cited for business background.

LQDA: finer powder, higher doses

Liquidia’s Yutrepia sales reached $170.4 million in Q2 2026, while a patent ruling threatens its PH-ILD label but leaves PAH sales and a…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 108

X accounts we follow

Every account on this site, hand-picked.

89 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.